Patents by Inventor David Threadgill

David Threadgill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of EGFR inhibitors to prevent or treat obesity
    Patent number: 8703769
    Abstract: Methods of treating or preventing obesity or obesity related disorders in a subject are provided, comprising administering to the subject a treatment effective in reducing one or more activities of an epidermal growth factor receptor (EGFR) in the subject. Methods of screening for compositions that can modulate one or more EGFR activities are also provided.
    Type: Grant
    Filed: July 14, 2006
    Date of Patent: April 22, 2014
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: David Threadgill, Cordelia Johnson Barrick
  • Modulation of epidermal growth factor heterodimer activity
    Patent number: 8323987
    Abstract: Provided is a method for screening a plurality of compounds for an ability to bind to a heterodimer of EGFR and another ERBB family member. Also provided are compounds that bind to heterodimers of EGFR and another ERBB family member, and methods of using the identified compounds to suppress the growth of a tumor associated with EGFR heterodimer activity in a subject.
    Type: Grant
    Filed: February 17, 2005
    Date of Patent: December 4, 2012
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: David Threadgill, Daekee Lee
  • Modulation of epidermal growth factor heterodimer activity
    Publication number: 20100015124
    Abstract: Provided is a method for screening a plurality of compounds for an ability to bind to a heterodimer of EGFR and another ERBB family member. Also provided are compounds that bind to heterodimers of EGFR and another ERBB family member; and methods of using the identified compounds to suppress the growth of a tumor associated with EGFR heterodimer activity in a subject.
    Type: Application
    Filed: February 17, 2005
    Publication date: January 21, 2010
    Inventors: David Threadgill, Daekee Lee
  • Use of egfr inhibitors to prevent or treat obesity
    Publication number: 20090202529
    Abstract: Methods of treating or preventing obesity or obesity related disorders in a subject are provided, comprising administering to the subject a treatment effective in reducing one or more activities of an epidermal growth factor receptor (EGFR) in the subject. Methods of screening for compositions that can modulate one or more EGFR activities are also provided.
    Type: Application
    Filed: July 14, 2006
    Publication date: August 13, 2009
    Inventors: David Threadgill, Cordelia Johnson Barrick